HIV Vaccine Trials

EVF has sponsored or co-sponsored multiple phase I/II clinical trials in Europe and Africa, in both prophylactic and therapeutic settings.

The lead candidates in EVF’s clinical program is based on DNA and NYVAC combination.

These trials are funded and co-funded by European Commission 5th and 7th Framework Programs, Agence nationale de recherches sur le sida et les hépatites virales (ANRS) of Inserm, International HIV Vaccine Trial Network (IAVI), HIV Vaccine Trial Network (HVTN)/National Institute of Health (NIH) and European and Developing Countries Clinical Trials Partnership (EDCTP).